Opus Genetics (IRD) Other Working Capital Changes (2010 - 2026)

Opus Genetics (IRD) has 17 years of Other Working Capital Changes data on file, last reported at $2.1 million in Q1 2026.

• On a quarterly basis, Other Working Capital Changes rose 64.25% year-over-year to $2449.0 in Q3 2020; TTM through Sep 2020 was $7242.0, a N/A change from a year earlier, with the FY2019 full-year figure at -$3724.0, down 110.11% from the prior year.
• Other Working Capital Changes for Q3 2020 stood at $2449.0, up from $1810.0 in the prior quarter.
• Over the last five years, Other Working Capital Changes for IRD reached as high as $4373.0 in Q1 2019 and fell as low as -$11079.0 in Q2 2019.
• Historically, Other Working Capital Changes has averaged $150764.7 across 5 years, with a median of -$135000.0 in 2022.
• Across the five-year window, Other Working Capital Changes sank 237.74% in 2022 and surged 2602.78% in 2025, its largest moves.
• Year by year, Other Working Capital Changes stood at $1491.0 in 2019, then jumped by 64.25% to $2449.0 in 2020.
• Per Business Quant data, the three most recent Other Working Capital Changes figures were $2449.0 in Q3 2020, $1810.0 in Q2 2020, and $1492.0 in Q1 2020.